Skip to main content

Speed Learning 2: COVID-19 Pooling, NAAT for M. genitalium, Molecular Characterization

From the 2022 Joint Annual Meeting (recorded 6/28/2022)
Presented by Sasha Tittel, Brian Smith and Peter Wasik

This speed learning session includes 3 presentations:
COVID-19 Pooling
The Department of Defense has the capability of pooled testing methodology for COVID-19. The goal of this presentation is to learn the many benefits of pooled testing to include increasing your laboratory’s testing volume while using less reagents and much more.

Evaluation of a Nucleic Acid Amplification Test for the Detection of Mycoplasma genitalium in a Military Treatment Facility
Mycoplasma genitalium is an emerging cause of sexually transmitted infections (STI). This presentation includes the study of the prevalence rate of M. genitalium in our patient population to determine an appropriate testing algorithm.

Molecular Characterization of Influenza and SARS-CoV-2 in DoD Beneficiaries During the COVID-19 Pandemic
The Department of Defense Global Respiratory Pathogen Surveillance Program (DoDGRPSP), a year-round sentinel-based program, conducts surveillance on influenza, an array of non-influenza respiratory pathogens, and now Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This presentation will give an overview of the DoDGRPSP, provide surveillance data on respiratory viruses circulating during the 2021-2022 influenza season, and provide influenza and SARS-CoV-2 sequencing results.

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:

  • Describe what pooled COVID-19 testing means.
  • Calculate and be able to identify when the best time may be to utilize COVID-19 pooled testing.
  • Describe resources to help you verify your instrumentation for pooled testing.
  • Identify diagnostic and workflow methods for M. genitalium testing.
  • Summarize biological characteristics and symptom presentations of M. genitalium.
  • Summarize the prevalence of M. genitalium and potential future research.
  • Describe the DoD Global Respiratory Pathogen Surveillance Program’s role, objectives, and ability in conducting public health surveillance for respiratory pathogens among the military population.
  • Discuss surveillance data on respiratory viruses

CE ACCREDITATION
ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of Microbiology will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.


LEVEL OF INSTRUCTION
This Intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.